Home/Hallux/Mark T. Taylor

MT

Mark T. Taylor

Co-Founder, CEO, Board Member

Therapeutic Areas

Dermatology Infectious Disease

Hallux Pipeline

Drug	Indication	Phase
Hallux Subungual Gel (HSG)	Onychomycosis (fungal nail infection)	Phase 2a

Leadership Team at Hallux

Jay E. Birnbaum, PhD

Co-Founder, Board Member

William P. Forbes, PharmD

Board Member & Consultant (Product Development & CMC)

Seth M. Birnbaum

View full Hallux profile